Clinical Trials Logo

Aneurysm clinical trials

View clinical trials related to Aneurysm.

Filter by:

NCT ID: NCT05254067 Enrolling by invitation - Aneurysm Clinical Trials

Enterprise 2 Vascular Reconstruction Device

Start date: February 28, 2017
Phase:
Study type: Observational

The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.

NCT ID: NCT05155956 Enrolling by invitation - Clinical trials for Thoracic Aortic Aneurysm

Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System

CHaMP
Start date: December 15, 2021
Phase:
Study type: Observational

This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.

NCT ID: NCT04269447 Enrolling by invitation - Aortic Aneurysm Clinical Trials

Prospective Aortic Biobank of POP-STAR

Start date: November 18, 2019
Phase:
Study type: Observational [Patient Registry]

The overall objective of the POP-STAR project is individualized surveillance for patients diagnosed with abdominal aortic aneurysms by means of more precise, patient-specific AAA growth prediction.

NCT ID: NCT04224051 Enrolling by invitation - Clinical trials for Abdominal Aortic Aneurysm

Metformin for Abdominal Aortic Aneurysm Growth Inhibition

MAAAGI
Start date: February 12, 2020
Phase: Phase 2
Study type: Interventional

A multi-centre population-based open-label randomized controlled trial with allocation concealment and blinded outcome assessment will examine if up to 2g metformin daily slows AAA growth in patients with small AAAs who do not have diabetes.

NCT ID: NCT04035356 Enrolling by invitation - Aortic Aneurysm Clinical Trials

HAART Annuloplasty Device Valve Repair Registry

Start date: September 22, 2020
Phase:
Study type: Observational [Patient Registry]

Multicenter US registry study to assess procedure success and long-term (10-year) performance of the HAART 200 and HAART 300 Aortic Annuloplasty Devices when used during aortic valve repair in a routine cardiovascular practice setting.

NCT ID: NCT03823482 Enrolling by invitation - Aneurysm, Cerebral Clinical Trials

Lidocaine and Perioperative Cytokine Levels in Blood and Cerebrospinal Fluid in Cerebral Aneurysm Patients

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Cerebral aneurysm surgery has significant mortality and morbidity rate. Inflammation plays a key role in the pathogenesis of intracranial aneurysms, their rupture, subarachnoid haemorrhage and neurologic complications. Brain injury activates immune cells and triggers cytokine release. Cytokine level in blood and cerebrospinal fluid is an indicator of inflammatory response. Cytokines contribute to secondary brain injury and can worsen the outcome of the treatment. Preventing secondary brain injury by modulating inflammatory response represents a therapeutic target. Lidocaine is local anesthetic that can be used in neurosurgery for regional anesthesia of the scalp and for topical anesthesia of the throat prior to direct laryngoscopy and endotracheal intubation. Except analgetic, lidocaine has systemic anti-inflammatory and neuroprotective effect. It acts through several mechanisms on various types of immune cells producing immunosuppressing effect. Lidocaine can act on activated microglia within central nervous system causing attenuation of immune response. Primary aim of this prospective randomized trial is to determine influence of lidocaine administration on inflammatory cytokine levels in serum and cerebrospinal fluid during and following cerebral aneurysm surgery. Secondary aim is to determine possible correlation between levels of cytokines and incidence of neurologic and infectious postoperative complications. For that purpose, postoperative neurological clinical status will be recorded. Signs of vasospasm and pathological postoperative brain CT scan findings will be recorded. Incidence of meningitis, pneumonia and sepsis in postoperative period will also be analyzed. Hypothesis of this trial is that lidocaine administration during cerebral aneurysm surgery would significantly change levels of pro-inflammatory cytokines in cerebrospinal fluid and serum. Lower concentrations of pro-inflammatory cytokines can possibly contribute to better outcome and significantly lower incidence of postoperative complications. Enzyme-immunochemical analysis will be used to measure levels of interleukin-1β, interleukin-6 and tumor necrosis factor-α in cerebrospinal fluid and serum. Investigation group will have, during cerebrovascular surgery under general anesthesia, regional anesthesia of the scalp and topical anesthesia of the throat prior to laryngoscopy, all done with lidocaine. Control group will have general anesthesia without lidocaine administration.

NCT ID: NCT03454633 Enrolling by invitation - Dialysis Clinical Trials

A Comparative Study of Different Hypothermic Circulatory Arrest Strategies on Aortic Surgery.

Start date: August 3, 2018
Phase: N/A
Study type: Interventional

By comparing the clinical outcome of patients underwent different hypothermic circulatory arrest (mild hypothermic versus moderate hypothermic) during aortic arch surgery, this study aims to determine the optimal hypothermic circulatory arrest strategy for aortic surgery.

NCT ID: NCT03140020 Enrolling by invitation - Aneurysm Clinical Trials

Cognition and Functional Connectivity After Elective Treatment of Brain Aneurysms

Start date: January 8, 2018
Phase: N/A
Study type: Observational

The aim of this proposal is to investigate the effects of uneventful microsurgical and endovascular treatment of unruptured saccular non-giant anterior communicating artery [ACoA] aneurysms on resting state functional connectivity levels of higher order cognitive networks and to correlate the connectivity levels of these networks with neuropsychological performance and functional outcome. This study compares two treatment groups and one control group.

NCT ID: NCT02638701 Enrolling by invitation - Stroke Clinical Trials

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Start date: July 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms

NCT ID: NCT02581904 Enrolling by invitation - Clinical trials for Peripheral Arterial Disease

Prevena Vascular Groin Wound Study

Start date: January 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if the application of a negative pressure dressing intraoperatively (Prevena; KCI, Inc) to vascular groin incisions decreases the wound complication rate in high risk patients.